LB42708 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent and selective inhibitor of certain enzymes that play a critical role in tumor growth and progression. Researchers employ LB42708 to investigate its potential in disrupting signaling pathways that are often hijacked by cancer cells, thereby halting their proliferation. Its application extends to preclinical studies where it is used to assess efficacy and safety in animal models, providing valuable insights for the development of targeted anticancer drugs. Additionally, LB42708 is instrumental in exploring combination therapies, where it is tested alongside other chemotherapeutic agents to enhance treatment outcomes and overcome drug resistance.